Xu XX - Search Results

1

[A comparative study of fludarabine-based versus CHOP-like regimens in untreated primary indolent lymphoma].

Xu XX, Yan B, Wang ZX, Yu Y, Yang HL, Zhao DD, Wang YF, Wu XX, Zhang YZ. Xu XX, et al. Zhonghua Xue Ye Xue Za Zhi. 2013 Oct;34(10):900-3. doi: 10.3760/cma.j.issn.0253-2727.2013.10.017. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 24171969 Chinese. No abstract available.

2

Novel therapy for NK/T cell lymphoma.

Xu XX, Zhang YZ. Xu XX, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Dec;20(6):1501-6. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012. PMID: 23257462 Review.

3

Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review.

Xu X, Zhang L, Wang Y, Zhang Q, Zhang L, Sun B, Zhang Y. Xu X, et al. Int J Clin Exp Pathol. 2013;6(4):788-94. Epub 2013 Mar 15. Int J Clin Exp Pathol. 2013. PMID: 23573328 Free PMC article. Review.

4

Fludarabine-based versus CHOP-like regimens with or without rituximab in patients with previously untreated indolent lymphoma: a retrospective analysis of safety and efficacy.

Xu XX, Yan B, Wang ZX, Yu Y, Wu XX, Zhang YZ. Xu XX, et al. Onco Targets Ther. 2013 Oct 8;6:1385-92. doi: 10.2147/OTT.S47764. eCollection 2013. Onco Targets Ther. 2013. PMID: 24143112 Free PMC article.

5

Evaluation of the clinical characteristics and prognostic factors of gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma.

Xu X, Wang Z, Yu Y, Wang Y, Zhang L, Sun B, Da W, Zhang Y. Xu X, et al. J Gastroenterol Hepatol. 2014 Sep;29(9):1678-84. doi: 10.1111/jgh.12615. J Gastroenterol Hepatol. 2014. PMID: 24730769

6

Primary rectal squamous cell carcinoma treated with surgery and radiotherapy.

Wang JF, Wang ZX, Xu XX, Wang C, Liu JZ. Wang JF, et al. Among authors: xu xx. World J Gastroenterol. 2014 Apr 14;20(14):4106-9. doi: 10.3748/wjg.v20.i14.4106. World J Gastroenterol. 2014. PMID: 24744603 Free PMC article.

7

Discoidin Domain Receptor 2: A New Target in Cancer.

Xu X, Yu T, Wang Z. Xu X, et al. Oncol Res Treat. 2022;45(4):205-215. doi: 10.1159/000519645. Epub 2022 Jan 24. Oncol Res Treat. 2022. PMID: 35073544 Free article. Review.

8

Delineation of features, responses, outcomes, and prognostic factors in pediatric PDGFRB-positive acute lymphoblastic leukemia patients: A retrospective multicenter study.

Zhang X, Wang Y, Tian X, Sun L, Jiang H, Chu J, Zhou F, Shen S, Hu S, Fang Y, Lai C, Ju X, Xu X, Zhai X, Jiang H, Yang M, Leung AWK, Xue N, Zhang Y, Yang J, Pui CH, Yu J, Gao J, Hu Q, Zhu X. Zhang X, et al. Cancer. 2024 Nov 15;130(22):3902-3912. doi: 10.1002/cncr.35481. Epub 2024 Aug 13. Cancer. 2024. PMID: 39136180

9

Characterization and quantification of the phytochemical constituents and anti-inflammatory properties of Lindera aggregata.

Wen SS, Liu YJ, Liu YL, Zhao Y, Xu XX, Guo CC, Niu C, Wang WJ, Xu YW, Zhang N. Wen SS, et al. Among authors: xu xx. RSC Adv. 2024 Nov 11;14(48):36101-36114. doi: 10.1039/d4ra05643d. eCollection 2024 Nov 4. RSC Adv. 2024. PMID: 39529747 Free PMC article.

10

Multi Targeted Therapy for Alzheimer's Disease by Guanidinium-Modified Calixarene and Cyclodextrin Co-Assembly Loaded with Insulin.

Zhang QY, Wang Q, Fu JX, Xu XX, Guo DS, Pan YC, Zhang T, Wang H. Zhang QY, et al. Among authors: xu xx. ACS Nano. 2024 Nov 5. doi: 10.1021/acsnano.4c05693. Online ahead of print. ACS Nano. 2024. PMID: 39499644

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

511 results

Search Page

Filters